You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ENGOT-EN20

Showing 1 - 25 of 3,909
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial (MK-2870, Doxorubicin, Paclitaxel)

Not yet recruiting
  • Endometrial Cancer
  • MK-2870
  • +2 more
  • (no location specified)
Nov 10, 2023

Endometrial Cancer Trial in Copenhagen (Palbociclib/, Letrozole)

Completed
  • Endometrial Cancer
  • Copenhagen, Sjaelland, Denmark
    NSGO-CTU
Jan 7, 2022

Endometrial Tumors Trial in Worldwide (pembrolizumab, carboplatin, paclitaxel)

Recruiting
  • Endometrial Neoplasms
  • pembrolizumab
  • +4 more
  • Miami Beach, Florida
  • +106 more
Aug 11, 2022

Marijuana Abuse Trial in New York (3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition,

Recruiting
  • Marijuana Abuse
  • 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition
  • 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fasting condition
  • New York, New York
    Substance Use Research Center
Jan 25, 2023

Endometrial Cancer Trial in Copenhagen (Nintedanib or Placebo; Carboplatin, Paclitaxel)

Completed
  • Endometrial Cancer
  • Nintedanib or Placebo; Carboplatin, Paclitaxel
  • Copenhagen, Sjaelland, Denmark
    NSGO
Jan 7, 2022

Uterine Cervical Tumors Trial in Worldwide (Nintedanib, Placebo)

Active, not recruiting
  • Uterine Cervical Neoplasms
  • Bruxelles, Belgium
  • +31 more
Mar 1, 2022

Endometrial Tumors Trial in China (Lenvatinib, Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Endometrial Neoplasms
  • Hefei, Anhui, China
  • +21 more
May 6, 2022

Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

Recruiting
  • Endometrial Cancer
  • Miami Beach, Florida
  • +6 more
Jan 31, 2023

Class II Division 1 Malocclusion Trial in Aleppo (PRP injection, En-masse retraction of upper anterior teeth)

Completed
  • Class II Division 1 Malocclusion
  • PRP injection
  • En-masse retraction of upper anterior teeth
  • Aleppo, Syrian Arab Republic
    Department of Orthodontics, Faculty of Dentistry, Aleppo Univers
Nov 10, 2023

Marijuana Abuse Trial in Madison (AEF0117)

Recruiting
  • Marijuana Abuse
  • Madison, Wisconsin
    Labcorp Clinical Research Unit Inc.
Jan 24, 2023

Class II Malocclusion, Division 1 Trial in Damascus (Electrical stimulation, Traditional retraction of the front upper teeth)

Completed
  • Class II Malocclusion, Division 1
  • Electrical stimulation
  • Traditional retraction of the front upper teeth
  • Damascus, Syrian Arab Republic
    Department of Orthodontics, Faculty of Dentistry, University of
Jun 17, 2023

Ovarian Cancer Trial in Worldwide (NovoTTF-100L(O), Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +118 more
Apr 19, 2022

Language, Methylphenidate of Undetermined Intent Trial in Nijmegen (Methylphenidate 20 Mg Oral Tablet, Placebo, Language Task)

Completed
  • Language
  • Methylphenidate of Undetermined Intent
  • Methylphenidate 20 Mg Oral Tablet
  • +8 more
  • Nijmegen, Gelderland, Netherlands
    Donders Institute for Brain, Cognition and Behaviour, Centre for
Mar 21, 2022

Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Short Regimen with Rifapentine 10mg/kg
  • +3 more
  • Guiyang, Guizhou, China
  • +5 more
May 28, 2022

Endometrial Tumors Trial in Worldwide (biological, drug, radiation)

Recruiting
  • Endometrial Neoplasms
  • Pembrolizumab
  • +8 more
  • Birmingham, Alabama
  • +228 more
Jul 29, 2022

SARS-CoV-2 Infection Trial in Mexico (AVX-COVID/12, ChAdOx-1-S[recombinant])

Recruiting
  • SARS-CoV-2 Infection
  • AVX-COVID/12
  • ChAdOx-1-S[recombinant]
  • Mexico City, Cdmx, Mexico
  • +13 more
Feb 3, 2023

Durability Study of EN3835 for Treatment of AC of Shoulder

Terminated
  • Adhesive Capsulitis
  • Frozen Shoulder
  • Previously treated with EN3835 up to 1.74 mg or Placebo in EN3835-210 or the pivotal phase 3 studies
  • Birmingham, Alabama
  • +29 more
Dec 28, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (Pembrolizumab, Placebo for pembrolizumab,

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +7 more
  • Birmingham, Alabama
  • +226 more
Aug 22, 2022

Covid19 Trial in Mexico (Azithromycin / Ivermectin / Ribaroxaban / Paracetamol, Azithromycin / Ribaroxaban / Paracetamol)

Completed
Has Results
  • Covid19
  • Azithromycin / Ivermectin / Ribaroxaban / Paracetamol
  • Azithromycin / Ribaroxaban / Paracetamol
  • Mexico, Distrito Federal, Mexico
    Alma Italia Guerrero Martinez
Aug 12, 2021

Endometrial Cancer Trial in Worldwide (Selinexor, Matching for selinexor)

Active, not recruiting
  • Endometrial Cancer
  • Tucson, Arizona
  • +104 more
Aug 11, 2022

Marijuana Abuse Trial in United States (AEF0117, Placebo oral capsule)

Recruiting
  • Marijuana Abuse
  • Los Angeles, California
  • +8 more
Jan 25, 2023

Severe Sepsis, Shock, Septic, Acute Kidney Injury Trial in France (56 days of weight-adjusted L-Carnitine treatment, 10 days of

Recruiting
  • Severe Sepsis
  • +2 more
  • 56 days of weight-adjusted L-Carnitine treatment
  • 10 days of intravenous placebo (isotonic saline)
  • Caen Cedex 9, France
  • +13 more
Mar 8, 2022

Intestinal Microbiota in Locally Advanced or Metastatic

Recruiting
  • Urothelial Carcinoma
  • Blood test
  • +2 more
  • Montpellier, Hérault, France
  • +9 more
Dec 23, 2021

NSCLC (NSCLC) Trial in Worldwide (Durvalumab)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer (NSCLC)
  • Gainesville, Georgia
  • +27 more
Dec 20, 2022

SARS CoV 2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2, Placebo)

Recruiting
  • SARS CoV 2 Infection
  • Recombinant NDV Vectored Vaccine for SARS-CoV-2
  • Placebo
  • Mexico City, Cdmx, Mexico
  • +3 more
Mar 23, 2022